NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/21/2018
Back to search
Official data from USPTO
MIDWEST INSTITUTE FOR CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MIDWEST INSTITUTE FOR CLINICAL RESEARCH
ST13
US500000075249759Class
42
Filing
75249759
Registration
2158565
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
05/21/2018
Trademark type
Word
Nice classes
42
Filing date
02/28/1997
Registration date
05/19/1998
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2018
Last transaction
05/21/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1990-06-00
First use in commerce
1990-06-00
Drawing code
1
Owner type
03
Owner location
Indianapolis, IN, US
Examiner
VAVONESE, DANIEL P
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Midwest Institute for Clinical Research, Inc.
Representatives
WILLIAM F BAHRET BAHRET & ASSOCIATES
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research in the pharmaceutical and medical fields
Publications
History of USPTO decisions and trademark events.
21 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/21/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/21/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/21/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
05/10/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/19/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/12/2008
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/12/2008
PLGL
ASSIGNED TO PARALEGAL
08/28/2008
E89R
TEAS SECTION 8 & 9 RECEIVED
08/20/2008
CFIT
CASE FILE IN TICRS
08/15/2007
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/22/2004
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
05/11/2004
E815
TEAS SECTION 8 & 15 RECEIVED
05/11/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/1998
PUBO
PUBLISHED FOR OPPOSITION
02/24/1998
NPUB
NOTICE OF PUBLICATION
01/23/1998
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/1997
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/1997
CNRT
NON-FINAL ACTION MAILED
09/29/1997
DOCK
ASSIGNED TO EXAMINER
09/25/1997
Continuous trademark protection
Get notified about every new filing that threatens MIDWEST INSTITUTE FOR CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.